Experimental Schistosoma haematobium pulmonary hypertension

1 February 2024

Biruk Kassa, Dara C. Fonseca-Balladares, Rahul Kumar, Michael H. Lee, Claudia Mickael, Linda Sanders, Kevin Nolan, Brian B. Graham

https://doi.org/10.1002/pul2.12336

Abstract

Whether all Schistosoma species cause pulmonary hypertension (PH) is unclear. Experimentally exposing mice to Schistosoma haematobium eggs caused PH, which was less severe than that induced by S. mansoni exposure. These findings align with the relatively uncommon reports of pulmonary arterial hypertension associated with S. haematobium.

Read the full research letter

Share:

Other materials on this topic

29 May 2024

Bacteria: iPVD Microbes Virtual Symposium series

'Bacteria' is part of the Microbes Virtual Symposium series by the iPVD, a global education programme that highlights top-notch research on inflammation and infectious PVD.

IDDI Workstream or Task Force Learning
3 January 2024

A rare sequelae of esophageal perforation: Fibrosing mediastinitis

Fibrosing mediastinitis (FM) is a rare disease caused by different causes. If left untreated, the prognosis is poor. The common causes of FM are Tuberculosis and Histoplasma capsulatum infection. Esophageal perforation is also a rare condition...

Pulmonary Circulation
Additional comments are available to members. Login or register to become a member today
RegisterorLogin to view

More from Pulmonary Circulation

Show more details

A collection of up-to-date abstracts from our premier, international, peer-reviewed, medical research journal dedicated exclusively to pulmonary circulation and pulmonary vascular disease. 

Pulmonary vascular disease, environmental pollution, and climate change
Human pulmonary microvascular endothelial cells respond to DAMPs from injured renal tubular cells
Creating a digital approach for promoting physical activity in pediatric pulmonary hypertension: A framework for future interventions
Balloon pulmonary angioplasty for chronic thromboembolic pulmonary disease without pulmonary hypertension
A systematic review of the impact of pulmonary thromboendarterectomy on health-related quality of life
Treatment and management of chronic thromboembolic pulmonary hypertension (CTEPH): A global cross-sectional scientific survey (CLARITY)
Ruptured pulmonary arteriovenous fistula causing hemothorax in a patient with hereditary hemorrhagic telangiectasia: A case report
A perfectly imperfect engine: Utilizing the digital twin paradigm in pulmonary hypertension
Nonsurgical treatment of a patient with decompensated right ventricular failure due to chronic thromboembolic pulmonary hypertension with proximal clot location—A case report
The European Voice of the Patient living with pulmonary hypertension associated with interstitial lung disease: Diagnosis, symptoms, impacts, and treatments
Excess healthcare resource utilization and costs for commercially insured patients with pulmonary arterial hypertension: A real-world data analysis
Demographic, hemodynamic characteristics, and therapeutic trends of pulmonary hypertension patients: The Pulmonary Hypertension Mexican registry (REMEHIP)
Cardiopulmonary exercise testing and the 2022 definition of pulmonary hypertension
Association of mildly elevated pulmonary vascular resistance with major cardiovascular events in pulmonary hypertension and chronic kidney disease: A retrospective cohort analysis
Evaluating the technical use of a Fitbit during an intervention for patients with pulmonary arterial hypertension with quality of life as primary endpoint: Lessons learned from the UPHILL study